News

MINIjectTM longer-term data at ESCRS

The latest results from the European STAR-II trial of MINIjectTM, iSTAR Medical’s minimally invasive glaucoma surgery device (MIGS), will be presented at the 39th edition of the European Society of Cataract and Refractive Surgeons (ESCRS) annual meeting. ESCRS is taking place between October 8 and 11 in Amsterdam, the Netherlands. Professor Julián García Feijoó, Universidad Complutense, […]

iSTAR Medical’s Supraciliary MIGS presented at IGC

MINIjectTM, iSTAR Medical’s minimally invasive glaucoma surgery (MIGS) device, will be presented as part of the “On the Cutting Edge” talks during the opening session at the prestigious, invitation-only Interventional Glaucoma Congress (IGC) meeting in Chicago from 7 to 11 October 2021. Dr Brian Flowers, who will present iSTAR Medical’s technology, specializes in glaucoma and […]

MINIject’s data presented at European Ophthalmology Futures Forum, Virtual 2021

iSTAR Medical was selected for a presentation at the virtual European Ophthalmology Futures Forum this Thursday 7 October, where CEO Michel Vanbrabant will present competitive strengths for iSTAR Medical’s revolutionary MIGS device MINIjectTM.

Preliminary, interim, three-year MINIjectTM data show strong performance and no ECD safety concerns

Promising preliminary, interim three-year data on iSTAR Medical’s Minimally Invasive Glaucoma Surgery (MIGS) device, MINIjectTM, showed strong performance and no endothelial cell density (ECD) safety concerns in glaucoma patients, confirming the positive trend observed so far as part of the STAR-I trial. The data have been presented at the Deutsche Ophthalmologische Gesellschaft (DOG) congress, the […]

MINIjectTM data featuring at German DOG virtual meeting

Results from MINIject’s European STAR-II trial and from the long-term follow-up trial STAR-GLOBAL will feature at the Deutsche Ophthalmologische Gesellschaft (DOG) congress, the annual meeting of the German Ophthalmology Society taking place 30 September to 3 October. The 18-month data from the European STAR-II trial will be presented on-demand by the global leading ophthalmologist, Professor […]